184 related articles for article (PubMed ID: 38166695)
21. Comparison of single trough-based area under the concentration-time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity.
Niwa T; Yasue M; Harada S; Yamada Y; Otsubo M; Yamada M; Matsuoka S; Yamamoto T; Mizusaki Y; Suzuki A
J Infect Chemother; 2022 Jul; 28(7):923-928. PubMed ID: 35379525
[TBL] [Abstract][Full Text] [Related]
22. Individualized dosing of vancomycin in geriatric patients.
Suchánková H; Lečbychová K; Strojil J; Fürst T
Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
[TBL] [Abstract][Full Text] [Related]
23. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Therapeutic Vancomycin Monitoring in Taiwan.
Chen TT; Liu MP; Sun HC
Microbiol Spectr; 2022 Apr; 10(2):e0156221. PubMed ID: 35412391
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
Abdelmessih E; Patel N; Vekaria J; Crovetto B; SanFilippo S; Adams C; Brunetti L
Pharmacotherapy; 2022 Sep; 42(9):741-753. PubMed ID: 35869689
[TBL] [Abstract][Full Text] [Related]
27. Model-Informed Precision Dosing Improves Outcomes in Patients Receiving Vancomycin for Gram-Positive Infections.
Hall NM; Brown ML; Edwards WS; Oster RA; Cordell W; Stripling J
Open Forum Infect Dis; 2024 Jan; 11(1):ofae002. PubMed ID: 38250202
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
Joseph K; Ramireddy K; Madison G; Turco T; Lui M
J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
[TBL] [Abstract][Full Text] [Related]
29. Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.
Oda K; Hashiguchi Y; Kimura T; Tsuji Y; Shoji K; Takahashi Y; Matsumoto K; Kawamura H; Saito H; Takesue Y
Pharm Res; 2021 Apr; 38(4):637-646. PubMed ID: 33782837
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results.
Kim B; Hwang S; Heo E; Kim HS; Jung J; Kim ES; Kim HB; Lee K; Park JS; Song J; Lee JH; Chung JY; Song KH; Yoon S
J Korean Med Sci; 2023 Apr; 38(14):e101. PubMed ID: 37038640
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin therapeutic drug monitoring in paediatrics.
Patel J; Lucas CJ; Ryan J; Jenkins M; Martin JH
J Paediatr Child Health; 2020 Apr; 56(4):563-570. PubMed ID: 31721353
[TBL] [Abstract][Full Text] [Related]
32. Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study.
Lu H; Duan L; Yu Y; Li J; Shi L; Xue S; Zhang Q; Zhou Q; Zhu C; Shang E; Yan X; Tang L
J Chemother; 2022 Nov; 34(7):446-458. PubMed ID: 35773225
[TBL] [Abstract][Full Text] [Related]
33. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
Horita Y; Asaoka M; Iida M; Kato H; Wachino C; Mitamura K; Ohashi K; Mimura Y; Hotta Y; Kataoka T; Nakamura A; Kimura K
Ther Drug Monit; 2023 Apr; 45(2):245-250. PubMed ID: 36006610
[TBL] [Abstract][Full Text] [Related]
34. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
[TBL] [Abstract][Full Text] [Related]
35. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin efficiency and safety of a dosage of 40-60 mg/kg/d and corresponding trough concentrations in children with Gram-positive bacterial sepsis.
Peng L; Guo Z; Zhang G; Tian X; Gu R; Li Q; Li Y; Luo Z
Front Cell Infect Microbiol; 2023; 13():1117717. PubMed ID: 37065209
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Antibiotic Stewardship: Optimization of Vancomycin Therapy Based on Individual Pharmacokinetics.
Kreitmeyr K; Pecar A; Mikolajczyk R; von Both U; Huebner J
Pediatr Infect Dis J; 2021 Jun; 40(6):556-562. PubMed ID: 33956756
[TBL] [Abstract][Full Text] [Related]
38. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
Ye ZK; Tang HL; Zhai SD
PLoS One; 2013; 8(10):e77169. PubMed ID: 24204764
[TBL] [Abstract][Full Text] [Related]
39. An Audit to Evaluate Vancomycin Therapeutic Drug Monitoring in a Neonatal Intensive Care Unit.
Alrahahleh D; Xu S; Zhu Z; Toufaili H; Luig M; Kim HY; Alffenaar JW
Ther Drug Monit; 2022 Oct; 44(5):651-658. PubMed ID: 35383737
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring of vancomycin in neurosurgery patients, from trough concentration to area under the curve: a retrospective single center cohort study in a tertiary hospital.
Chen Y; Kong X; Liu L
J Int Med Res; 2022 Mar; 50(3):3000605221083242. PubMed ID: 35264048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
